Dapagliflozin safely improves outcomes in people with apparent treatment-resistant hypertension: DELIVER Trial Medha Baranwal16 Oct 2023 11:30 AM ISTUSA: In a post hoc analysis of the DELIVER trial dapagliflozin was shown to be well-tolerated and consistently improved clinical outcomes, including...
Dietary Sodium Restriction Effective Against Treatment-Resistant Hypertension Jacinthlyn Sylvia4 Oct 2023 8:00 PM ISTFor patients with treatment-resistant hypertension (TRH), a condition associated with heightened cardiovascular risks, a new study suggests that a...
Baxdrostat use for BP control in patients with uncontrolled hypertension: HALO trial provides insight Medha Baranwal14 March 2023 11:30 AM ISTUSA: Recent data from the HALO trial showed that aldosterone synthase inhibition with baxdrostat was well-tolerated among patients with hypertension...
New drug, baxdrostat, offers hope to patients resistant to high blood pressure treatment: Phase 2 trial Dr Kartikeya Kohli9 Nov 2022 11:45 AM ISTThe highest dose of oral medication (Baxdrostat) in patients with treatment-resistant hypertension reduced blood pressure by 20 points.UK: A new class...
